2649 related articles for article (PubMed ID: 80402)
1. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. III. Antitumor activity of tallysomycins A and B.
Imanishi H; Ohbayashi M; Nishiyama Y; Kawaguchi H
J Antibiot (Tokyo); 1978 Jul; 31(7):667-74. PubMed ID: 80402
[TBL] [Abstract][Full Text] [Related]
2. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. V. Production, characterization and antitumor activity of tallysomycin S10b, a new biosynthetic tallysomycin derivative.
Miyaki T; Numata K; Nishiyama Y; Tenmyo O; Hatori M; Imanishi H; Konishi M; Kawaguchi H
J Antibiot (Tokyo); 1981 Jun; 34(6):665-74. PubMed ID: 6168631
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.
Lippman MM; Laster WR; Abbott BJ; Venditti J; Baratta M
Cancer Res; 1975 Apr; 35(4):939-45. PubMed ID: 1116151
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.
Fujimoto S; Ogawa M
Cancer Chemother Pharmacol; 1982; 8(2):157-62. PubMed ID: 7105379
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
Flora KP; van't Riet B; Wampler GL
Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062
[TBL] [Abstract][Full Text] [Related]
6. Tallysomycin S10b: experimental antitumor activity and toxicity.
Schurig JE; Rose WC; Hirth RS; Schlein A; Huftalen JB; Florczyk AP; Bradner WT
Cancer Chemother Pharmacol; 1984; 13(3):164-70. PubMed ID: 6207948
[TBL] [Abstract][Full Text] [Related]
7. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. II. Structure determination of tallysomycins A and B.
Konishi M; Saito K; Numata K; Tsuno T; Asama K
J Antibiot (Tokyo); 1977 Oct; 30(10):789-805. PubMed ID: 591444
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of spergualin, a novel antitumor antibiotic.
Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
[TBL] [Abstract][Full Text] [Related]
9. Relative pulmonary toxicity and antitumor effects of two new bleomycin analogs, pepleomycin and tallysomycin A.
Sikic BI; Siddik ZH; Gram TE
Cancer Treat Rep; 1980; 64(4-5):659-67. PubMed ID: 6159079
[TBL] [Abstract][Full Text] [Related]
10. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. IV. New biosynthetic derivatives of tallysomycin.
Miyaki T; Tenmyo O; Numata K; Matsumoto K; Yamamoto H; Nishiyama Y; Ohbayashi M; Imanishi H; Konishi M; Kawaguchi H
J Antibiot (Tokyo); 1981 Jun; 34(6):658-64. PubMed ID: 6168630
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor activity of the components of a carminomycin complex].
Shorin VA; Bazhanov VS; Averbukh LA
Antibiotiki; 1977 Jan; 22(1):69-74. PubMed ID: 576573
[TBL] [Abstract][Full Text] [Related]
12. Effects of levamisole (NSC-177023) and tetramisole (NSC-102063) in experimental tumor systems.
Johnson RK; Houchens DP; Gaston MR; Goldin A
Cancer Chemother Rep; 1975; 59(4):697-705. PubMed ID: 1175164
[TBL] [Abstract][Full Text] [Related]
13. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. I. Production, isolation and properties.
Kawaguchi H; Tsukiura H; Tomita K; Konishi M; Saito K
J Antibiot (Tokyo); 1977 Oct; 30(10):779-88. PubMed ID: 591443
[TBL] [Abstract][Full Text] [Related]
14. [Antineoplastic activity of antibiotic 1719 from the group of diazo compounds].
Shorin VA; Averbukh LA; Bazhanov VS; Lepeshkina GN; Grinshteĭn AM
Antibiotiki; 1972 Aug; 17(8):675-80. PubMed ID: 4678532
[No Abstract] [Full Text] [Related]
15. In vivo anti-cancer activity of RC-18: a plant isolate from Rubia cordifolia, Linn. against a spectrum of experimental tumour models.
Adwankar MK; Chitnis MP
Chemotherapy; 1982; 28(4):291-3. PubMed ID: 7116981
[TBL] [Abstract][Full Text] [Related]
16. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
Dawson KM
Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
[TBL] [Abstract][Full Text] [Related]
17. Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1.
Khan AH; Driscoll JS
J Med Chem; 1976 Feb; 19(2):313-7. PubMed ID: 1249812
[TBL] [Abstract][Full Text] [Related]
18. 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.
Agrawal KC; Schenkman JB; Denk H; Mooney PD; Moore EC; Wodinsky I; Sartorelli AC
Cancer Res; 1977 Jun; 37(6):1692-6. PubMed ID: 870183
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.
Goldin A; Venditti JM; Geran R
Invest New Drugs; 1985; 3(1):3-21. PubMed ID: 3886588
[TBL] [Abstract][Full Text] [Related]
20. A new antitumor antibiotic, FR900840. III. Antitumor activity against experimental tumors.
Nishimura M; Nakada H; Kawamura I; Mizota T; Shimomura K; Nakahara K; Goto T; Yamaguchi I; Okuhara M
J Antibiot (Tokyo); 1989 Apr; 42(4):553-7. PubMed ID: 2542208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
